Aclaris Therapeutics, Inc.ACRSNASDAQ
LOADING
|||
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$0.13
Net Income/Share$-1.16
Operating CF/Share$-0.35
Free CF/Share$-0.64
Cash/Share$0.78
Book Value/Share$0.98
Tangible Book/Share$0.98
Equity/Share$0.98
Interest Debt/Share$0.02
CapEx/Share$0.29
Dividend/Share$0.00
Valuation
Market Cap$380.29M
Enterprise Value$357.28M
P/E Ratio-3.04P/S Ratio24.16P/OCF Ratio-10.03
P/FCF Ratio-4.82
P/B Ratio3.58P/TB Ratio3.58
EV/Sales22.70EV/EBITDA-5.69
Graham Valuation
Graham Number--
Graham Net-Net$0.36
Profitability
Earnings Yield-32.92%FCF Yield-20.73%ROE-102.77%ROIC-101.91%Return on Tangible Assets-80.71%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF-83.64%
CapEx/Revenue228.03%
CapEx/Depreciation60.33
SBC/Revenue60.08%
SG&A/Revenue135.62%
R&D/Revenue286.41%
Liquidity & Solvency
Debt/Equity0.02Debt/Assets0.01Debt/Market Cap0.01
Net Debt/EBITDA0.37
Current Ratio3.92Interest Coverage0.00xIncome Quality0.30Efficiency
Days Sales Outstanding109 days
Days Payables Outstanding275 days
Days Inventory0 days
Receivables Turnover3.36x
Payables Turnover1.33x
Inventory Turnover0.00x
Capital Structure
Tangible Assets$120.10M
Working Capital$74.96M
Invested Capital$78.20M
Intangibles/Assets0.00%